Identifying high-risk post-infarction patients by autonomic testing - Below the tip of the iceberg

Axel Bauer1

  • 1Medizinische Klinik und Poliklinik I, Munich University Clinic, Munich, Germany; German Center for Cardiovascular Research (DZHK), Germany.

Insights

Late mortality after myocardial infarction (MI) remains high, particularly in patients with preserved ejection fraction. Cardiac autonomic dysfunction identifies high-risk individuals, prompting new preventive strategies beyond traditional implantable cardioverter-defibrillator (ICD) therapy.

Area of Science:

  • Cardiology
  • Autonomic Nervous System Research
  • Medical Device Technology

Background:

  • Late mortality post-myocardial infarction (MI) remains a significant clinical challenge.
  • Sudden cardiac death is a primary cause of mortality in post-MI patients.
  • Current prophylactic implantable cardioverter-defibrillator (ICD) therapy is indicated for patients with left ventricular ejection fraction (LVEF) ≤35%, leaving a large patient group with LVEF >35% without specific preventive strategies.

Purpose of the Study:

  • To investigate the prognostic value of cardiac autonomic dysfunction in post-MI patients with preserved LVEF (LVEF >35%).
  • To identify high-risk post-MI patients with LVEF >35% using combinations of autonomic markers.
  • To evaluate novel preventive strategies for high-risk post-MI patients with LVEF 36-50% and cardiac autonomic dysfunction.

Main Methods:

  • Analysis of cardiac autonomic dysfunction markers in post-MI patients.
  • Risk stratification of post-MI patients with preserved LVEF based on autonomic markers.
  • Evaluation of the REFINE-ICD trial (traditional ICD implantation) and the SMART-MI trial (implantable cardiac monitors with remote monitoring).

Main Results:

  • Cardiac autonomic dysfunction provides important prognostic information in post-MI patients with preserved LVEF.
  • Combinations of autonomic markers can identify high-risk post-MI patients (LVEF >35%) with outcomes comparable to those with LVEF ≤35%.
  • Ongoing trials are testing ICDs and advanced monitoring for high-risk post-MI patients with autonomic dysfunction and LVEF 36-50%.

Conclusions:

  • Cardiac autonomic dysfunction is a crucial factor for risk stratification in post-MI patients with preserved LVEF.
  • Novel strategies targeting autonomic dysfunction and subclinical arrhythmias are needed for high-risk post-MI patients.
  • Future research and clinical trials are essential to refine preventive therapies for this vulnerable population.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
351
Exercise Stress Test01:26

Exercise Stress Test

Introduction
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
1.6K
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
314
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
427
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
586